THE POTENCIES OF AUTOLOGOUS-CONDITIONED PLASMA FOR THE TREATMENT OF OSGOOD–SCHLATTER DISEASE: A LITERATURE REVIEW

PANJI SANANTA, YUDHA ANANTHA KHAERUL PUTRA, EKA NOVIYA FUZIANINGSIH

Abstract


Osgood-Schlatter disease (OSD) is characterized by inflammation of the patellar ligament at the tibial tuberosity resulting from growth-related overuse. Traction apophysitis of the anterior component of the tibial tuberosity (ATT) happens when the quadriceps muscle contracts at the point where the proximal tibial apophysis attaches to the tibia. The recommended interventions include the administration of analgesics, the provision of instruction on physical activity, and the implementation of physiotherapy. However, the duration of signs and symptoms can be extended. Autologous-conditioned plasma (ACP) injections are increasingly being employed in treating various musculoskeletal diseases due to their elevated concentration levels of growth factors compared to whole blood. The Autologous Concentrated Platelets (ACP) solution consists solely of platelet-rich plasma (PRP) devoid of leukocytes. This concentrated PRP will be administered via injection into the affected trauma region. The present literature evaluation used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) methodology. The current literature review demonstrates that autologous conditioned plasma (ACP) is a suitable alternative therapy for osteochondritis dissecans (OSD). The efficacy of OSD treatment can be enhanced by administering autologous conditioned plasma (ACP) into the affected region. Using autologous conditioned plasma (ACP) to treat orthopaedic and traumatological conditions, such as OSD and other musculoskeletal injuries, has much potential as a therapeutic intervention in orthopaedics and traumatology.         


Keywords


autologous-conditioned plasma; Osgood–Schlatter disease; patellar ligament; and platelet-rich plasma.

Full Text:

PDF

References


Vaishya R, Azizi AT, Agarwal AK V V. Apophysitis of the Tibial Tuberosity (Osgood-Schlatter Disease): A Review. Cureus. 2016;8(9).

Bezuglov EN, Tikhonova АА, Chubarovskiy PV, Repetyuk АD, Khaitin VY, Lazarev AM UE. Conservative treatment of Osgood-Schlatter disease among young professional soccer players. Int Orthop. 2020;44(9):1737–43.

Holden S, Olesen JL, Winiarski LM, Krommes K, Thorborg K, Hölmich P RM. Is the Prognosis of Osgood-Schlatter Poorer Than Anticipated? A Prospective Cohort Study With 24-Month Follow-up. Orthop J Sport Med. 2021;9(8).

Pascarella F, Ziranu A MG. Tibial tubercle fracture in a 14-year-old athlete with bilateral lower pole bipartite patella and osgood-schlatter disease. Case Rep Orthop. 2015;2015.

Nkaoui M EAE. Osgood-schlatter disease: risk of a disease deemed banal. Pan Afr Med J. 2017;28(56).

Zonfrillo MR, Spicer RS, Lawrence BA MT. Incidence and costs of injuries to children and adults in the United States. Inj Epidemology. 2018;5(1):37.

Corbi F, Matas S, Alvarez-Herms J, Sitko S, Baiget E, Reverter-Masia J L-LI. Osgood-Schlatter Disease: Appearance, Diagnosis and Treatment: A Narrative Review. Healthc. 2022;10(6):1011.

Danneberg DJ. Successful Treatment of Osgood-Schlatter Disease with Autologous-Conditioned Plasma in Two Patients. Joints. 2017;5(3):191–4.

Halilbašić A, Kreso A, Klepić M, Jaganjac A AD. The Algorithm for overload syndrome prevention: Osgood-Schlatter’s syndrome (OSD) as an overload syndrome caused by early inclusion of children in sports and excessive physical activity (sports and recreation). J Heal Sci. 2019;9(3).

Enomoto S, Tsushima A, Oda T KM. The Passive Mechanical Properties of Muscles and Tendons in Children Affected by Osgood-Schlatter Disease. J Pediatr Orthop. 2020;40(4):e243–7.

Lyng KD, Rathleff MS, Dean BJF, Kluzek S HS. Current management strategies in Osgood Schlatter: A cross-sectional mixed-method study. Scand J Med Sci Sport. 2020;30(10):1985–91.

Nakase J, Aiba T, Goshima K, Takahashi R, Toratani T, Kosaka M, Ohashi Y TH. Relationship between the skeletal maturation of the distal attachment of the patellar tendon and physical features in preadolescent male football players. Knee Surg Sport Traumatol Arthrosc. 2014;22(1):195–9.

Yanagisawa S, Osawa T, Saito K, Kobayashi T, Tajika T, Yamamoto A, Iizuka H TK. Assessment of Osgood-Schlatter Disease and the Skeletal Maturation of the Distal Attachment of the Patellar Tendon in Preadolescent Males. Orthop J Sport Med. 2014;2(7).

Watanabe H, Fujii M, Yoshimoto M, Abe H, Toda N, Higashiyama R TN. No Title. Pathog Factors Assoc With Osgood-Schlatter Dis Adolesc Male Soccer Play A Prospect Cohort Study. 2018;6(8).

Jibri Z, Jamieson P, Rakhra KS, Sampaio ML DG. Patellar maltracking: an update on the diagnosis and treatment strategies. Insights Imaging. 2019;10(1):65.

Gaulrapp H NC. The Osgood-Schlatter disease: a large clinical series with evaluation of risk factors, natural course, and outcomes. Int Orthop. 2022;46(2):197–204.

Green DW, Sidharthan S, Schlichte LM, Aitchison AH MD. Increased Posterior Tibial Slope in Patients With Osgood-Schlatter Disease: A New Association. 2020;48(3):642–6.

Mebis W, Jager T VHE. Intratendinous Patellar Ganglion Cyst with Coexistant Osgood Schlatter Disease. J Belgian Soc Radiol. 2016;100(1):86.

Hall R, Barber Foss K, Hewett TE MG. Sport specialization’s association with an increased risk of developing anterior knee pain in adolescent female athletes. J Sport Rehabil. 2015;24(1):31–5.

Cahalan R, Purtill H, O’Sullivan P OK. A cross-sectional study of elite adult Irish dancers: biopsychosocial traits, pain, and injury. J Danc Med Sci. 2015;19(1):31–43.

Cahalan R, Bargary N OK. Pain and Injury in Elite Adolescent Irish Dancers: A Cross-Sectional Study. J Danc Med Sci. 2018;22(2):91–9.

Nur Suhaila I, Siti Suhaila MY WAW. An active boy with bilateral knee pain. Malaysia Fam Phys. 2019;14(1):26–8.

Moy A, Song E, Wallace SJ, Teixeira R TD. Simultaneous Bilateral Patellar Tendon Rupture in a Young Adult Male: A Case Report and Review of the Literature. Cureus. 2020;129.

Kartini C W-S DI. Osgood-Schlatter disease: A review of current diagnosis and management. Cureus. 2022;33:294–8.

Sailly M, Whiteley R JA. Doppler ultrasound and tibial tuberosity maturation status predicts pain in adolescent male athletes with Osgood-Schlatter’s disease: a case series with comparison group and clinical interpretation. Br J Sports Med. 2013;47(2):93–7.

Guldhammer C, Rathleff MS, Jensen HP HS. Long-term Prognosis and Impact of Osgood-Schlatter Disease 4 Years After Diagnosis: A Retrospective Study. Orthop J Sport Med. 2019;7(10).

Kaya DO, Toprak U, Baltaci G, Yosmaoglu B OH. Long-term functional and sonographic outcomes in Osgood-Schlatter disease. Knee Surg Sport Traumatol Arthrosc. 2013;21(5):1131–9.

Ohtaka M, Hiramoto I, Minagawa H, Matsuzaki M KH. Screening of the Maturity Status of the Tibial Tuberosity by Ultrasonography in Higher Elementary School Grade Schoolchildren. Int J Environ Res Public Health. 2019;16(12):2138.

Hart E, Meehan WP 3rd, Bae DS, d’Hemecourt P SA. The Young Injured Gymnast: A Literature Review and Discussion. Curr Sport Med Reports. 2018;17(11):366–75.

Circi E, Atalay Y BT. Treatment of Osgood-Schlatter disease: review of the literature. Musculoskelet Surg. 2017;101(3):195–200.

Circi E BT. Results of arthroscopic treatment in unresolved Osgood-Schlatter disease in athletes. Int Orthop. 2017;41(2):351–6.

Yen YM. Assessment and treatment of knee pain in the child and adolescent athlete. Pediatr Clin North Am. 2014;61(6):1155–73.

Herrero-Morín JD, Fernández González N, Gutiérrez Díez C, Pérez Menéndez MT FFE. Enfermedad de Osgood-Schlatter en un adolescente deportista. Caso clínico [Osgood-Schlatter disease in adolescent athlete. Arch Argent Pediatr. 2017;115(6):445–8.

Morris E. Acupuncture in Osgood-Schlatter disease. BMJ Case Rep. 2016;

Ladenhauf HN, Seitlinger G GD. Osgood-Schlatter disease: a 2020 update of a common knee condition in children. Curr Opin Pediatr. 2020;32(1):107–12.

Neuhaus C, Appenzeller-Herzog C FO. A systematic review on conservative treatment options for OSGOOD-Schlatter disease. 2021;49:178–87.

Wise K, Warren D DL. Unilateral striae distensae of the knee after a steroid injection for the treatment of Osgood-Schlatter disease. Dermatol Online J. 2017;23(31).

Weiler R, Ingram M WR. 10-Minute Consultation. Osgood-Schlatter disease. BMJ. 2011;343.

Narayan N, Mitchell PD LM. Complete resolution of the symptoms of refractory Osgood-Schlatter disease following percutaneous fixation of the tibial tuberosity. BMJ Case Rep. 2015;

Lebiedziński R, Synder M, Buchcic P, Polguj M, Grzegorzewski A SM. A randomized study of autologous conditioned plasma and steroid injections in the treatment of lateral epicondylitis. Int Orthop. 2015;39(11):2199–203.

Omodaka T, Ohsawa T, Tajika T, Shiozawa H, Hasimoto S, Ohmae H, Shitara H, Ichinose T, Sasaki T, Hamano N, Takagishi K CH. Relationship Between Lower Limb Tightness and Practice Time Among Adolescent Baseball Players With Symptomatic Osgood-Schlatter Disease. Orthop J Sport Med. 2019;7(5).

Dohan Ehrenfest DM, Bielecki T, Mishra A, Borzini P, Inchingolo F, Sammartino G, Rasmusson L EP. In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes. Curr Pharm Biotechnol. 2012;13(7):1131–7.

Charousset C, Zaoui A, Bellaiche L BB. Are multiple platelet-rich plasma injections useful for treatment of chronic patellar tendinopathy in athletes? a prospective study. Am J Sports Med. 2014;42(4):906–11.

Arthrex Inc. Arthrex Double Syringe Ide-Pivotal. 2017;(January):1–98.

Baria M, Vasileff WK, Miller M, Borchers J, Flanigan DC DS. Cellular Components and Growth Factor Content of Platelet-Rich Plasma With a Customizable Commercial System. 2019;47(5):1216–22.

Genç E, Yüksel S, Çağlar A, Beytemur O GM. Comparison on effects of platelet-rich plasma versus autologous conditioned serum on Achilles tendon healing in a rat model. Acta Orthop Traumatol Turc. 2020;54(4):438–44.

Khurana A, Goyal A, Kirubakaran P, Akhand G, Gupta R GN. Efficacy of Autologous Conditioned Serum (ACS), Platelet-Rich Plasma (PRP), Hyaluronic Acid (HA) and Steroid for Early Osteoarthritis Knee: A Comparative Analysis. Indian J Orthop. 2020;55.

Lyras DN, Kazakos K, Verettas D, Polychronidis A, Tryfonidis M, Botaitis S, Agrogiannis G, Simopoulos C, Kokka A PE. The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing. Foot Ankle Int. 2009;30(11):1101–6.

Mishra AK, Skrepnik NV, Edwards SG, Jones GL, Sampson S, Vermillion DA, Ramsey ML, Karli DC RA. Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients. Am J Sports Med. 2014;42(2):463–71.

Vetrano M, Castorina A, Vulpiani MC, Baldini R, Pavan A FA. Platelet-rich plasma versus focused shock waves in the treatment of jumper’s knee in athletes. Br J Gen Pract. 2013;41(4):795–803.

G E. The Osgood-Schlatter lesion. A clinical and experimental study. Acta Chir Scand Suppl. 1962;288:1–36.




DOI: https://doi.org/10.26618/aimj.v8i1.15814

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Panji Sananta, Yudha Anantha Khaerul Putra, Eka Noviya Fuzianingsih

Creative Commons License
Al-Iqra Medical Journal: Jurnal Ilmiah Kedokteran under by Creative Commons Attribution-NoDerivatives 4.0 International License.